Position in FTRE
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$5,449,808
+$722,360 QoQ
Shares Held
578,536
+111.1% QoQ
Ownership
0.612%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 93.56721102921858.ToString("F0")%
Shared 0.ToString("F0")%
None 6.432788970781421.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Derivatives in FTRE
reported options exposure · as of Jun 30, 2025CallValue
$0
CallShares
0
PutValue
$1,235,000
PutShares
250,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,306,928,575 across 560 Biotechnology names. FTRE ranks #145 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in FTRE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,449,808 | 578,536 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,727,448 | 274,055 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $6,908,971 | 820,543 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,235,000 | 250,000 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $5,871,485 | 1,188,560 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,033,113 | 401,737 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $7,380,661 | 395,746 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,978,640 | 98,932 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,987,752 | 128,010 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,572,683 | 163,744 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,866,107 | 139,430 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $107,448,337 | 3,758,249 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $2,346 | 69 | Shares | Sole | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||